本報告書はPOC糖化ヘモグロビン検出器市場規模の世界市場の概要を紹介します。2020~2024年の歴史的な市場収益データ、2025年の予想、および2031年までのCAGRの予測を含む世界市場動向の分析。レポートはPOC糖化ヘモグロビン検出器の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。


世界のPOC糖化ヘモグロビン検出器市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートはPOC糖化ヘモグロビン検出器のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別にPOC糖化ヘモグロビン検出器市場を分類しています。本研究に含まれる主な企業は：Abbott、 Siemens Healthineers、 Roche、 Bio-Rad、 GREEN CROSS MEDIS、 Trinity Biotech、 HUMAN Diagnostics、 Sinocare (PTS Diagnostics)、 Erba Diagnostics、 EKF Diagnostics、 OSANG Healthcare、 SD Biosensor、 Aidian、 Boditech Med、 i-SENS

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ


タイプ別市場セグメント：
Immunoassay
Boronate Affinity
Others



用途別の市場セグメント：
Hospital and Clinics
Diagnostic Laboratories
Others



本レポートの詳細内容
世界のPOC糖化ヘモグロビン検出器市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、POC糖化ヘモグロビン検出器タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業のPOC糖化ヘモグロビン検出器収益、市場シェア、業界ランキング、2020年から2025年までのデータに焦点を当てています。世界のPOC糖化ヘモグロビン検出器市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、POC糖化ヘモグロビン検出器市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。



POC糖化ヘモグロビン検出器のレポートは2020年から2031年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。



章の概要
第1章：POC糖化ヘモグロビン検出器のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2020～2031）

第2章：POC糖化ヘモグロビン検出器の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2020～2031）

第3章POC糖化ヘモグロビン検出器企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2020～2031）

第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2020～2025）

第5章：POC糖化ヘモグロビン検出器の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2020～2031）

第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2020～2031）

第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2020～2031）

第8章：中国の種類別、および用途別、各セグメントの収益。（2020～2031）

第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2020～2031）

第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2020～2031）

第11章：POC糖化ヘモグロビン検出器の主要企業の概要を提供し、製品の説明と仕様、POC糖化ヘモグロビン検出器の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2020～2025）

第12章：アナリストの見解/結論

Valued at US$ 593 million in 2024, the global POC HbA1C Testing market is forecast to reach US$ 984 million by 2030, at a CAGR of 8.8% during the forecast period.

HbA1c levels, which reflect the average plasma glucose concentration over the preceding three months, play a pivotal role in the diagnosis, assessment, and monitoring of diabetes. HbA1c is your average blood glucose (sugar) levels for the last two to three months. The immediate feedback of HbA1c levels is highly effective for controlling plasma glucose levels and point-of-care (POC) instruments, characterized as fast, portable, and easy-to-use, have been shown to be suitable for providing rapid feedback of HbA1c levels. In this report, we mainly study the devices for POC HbA1C Testing without services.

Market Drivers:
The growing prevalence of diabetes worldwide is a key driver for the POC HbA1c testing market. As the number of diabetic and prediabetic patients continues to rise, there is an increasing need for quick and efficient monitoring solutions to manage blood sugar levels effectively. POC HbA1c testing provides immediate results, allowing for real-time clinical decision-making and reducing patient dependence on centralized laboratories. Additionally, advancements in technology have led to the development of highly accurate, portable, and user-friendly devices, expanding their adoption in hospitals, clinics, and even home settings. Government initiatives promoting early diabetes detection and personalized treatment plans further boost market growth.

Market Challenges:
Despite its advantages, POC HbA1c testing faces several challenges, including high costs and reimbursement limitations in some healthcare systems, which may hinder widespread adoption. Additionally, variations in accuracy and standardization among different POC devices pose concerns regarding result reliability, especially when compared to laboratory-based testing. Regulatory approvals and compliance with stringent quality standards also create barriers for manufacturers entering new markets. Furthermore, lack of awareness and limited access to POC testing in certain developing regions restricts its potential reach, requiring further investments in education and healthcare infrastructure.

Report Includes
This report presents an overview of global market for POC HbA1C Testing market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of POC HbA1C Testing, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for POC HbA1C Testing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the POC HbA1C Testing revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global POC HbA1C Testing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for POC HbA1C Testing revenue, projected growth trends, production technology, application and end-user industry.

Descriptive company profiles of the major global players, including Abbott, Siemens Healthineers, Roche, Bio-Rad, GREEN CROSS MEDIS, Trinity Biotech, HUMAN Diagnostics, Sinocare (PTS Diagnostics), Erba Diagnostics, EKF Diagnostics, etc.

Market Segmentation
By Company
Abbott
Siemens Healthineers
Roche
Bio-Rad
GREEN CROSS MEDIS
Trinity Biotech
HUMAN Diagnostics
Sinocare (PTS Diagnostics)
Erba Diagnostics
EKF Diagnostics
OSANG Healthcare
SD Biosensor
Aidian
Boditech Med
i-SENS

Segment by Type
Immunoassay
Boronate Affinity
Others

Segment by Application
Hospital and Clinics
Diagnostic Laboratories
Others

By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of South America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of POC HbA1C Testing in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of POC HbA1C Testing companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, POC HbA1C Testing revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global POC HbA1C Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Immunoassay
1.2.3 Boronate Affinity
1.2.4 Others
1.3 Market by Application
1.3.1 Global POC HbA1C Testing Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital and Clinics
1.3.3 Diagnostic Laboratories
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered

2 Global Growth Trends
2.1 Global POC HbA1C Testing Market Perspective (2020-2031)
2.2 Global POC HbA1C Testing Growth Trends by Region
2.2.1 Global POC HbA1C Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 POC HbA1C Testing Market Size by Region (2020-2031)
2.3 POC HbA1C Testing Market Dynamics
2.3.1 POC HbA1C Testing Industry Trends
2.3.2 POC HbA1C Testing Market Drivers
2.3.3 POC HbA1C Testing Market Challenges
2.3.4 POC HbA1C Testing Market Restraints

3 Competition Landscape by Key Players
3.1 Global Revenue POC HbA1C Testing by Players
3.1.1 Global POC HbA1C Testing Revenue by Players (2020-2025)
3.1.2 Global POC HbA1C Testing Revenue Market Share by Players (2020-2025)
3.2 Global POC HbA1C Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of POC HbA1C Testing, Ranking by Revenue, 2023 VS 2024 VS 2025
3.4 Global Market Concentration Ratio
3.4.1 Global POC HbA1C Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by POC HbA1C Testing Revenue in 2024
3.5 Global Key Players of POC HbA1C Testing Head office and Area Served
3.6 Global Key Players of POC HbA1C Testing, Product and Application
3.7 Global Key Players of POC HbA1C Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global POC HbA1C Testing Historic Market Size by Type (2020-2025)
4.2 Global POC HbA1C Testing Forecasted Market Size by Type (2026-2031)

5 Breakdown Data by Application
5.1 Global POC HbA1C Testing Historic Market Size by Application (2020-2025)
5.2 Global POC HbA1C Testing Forecasted Market Size by Application (2026-2031)

6 North America
6.1 North America POC HbA1C Testing Market Size (2020-2031)
6.2 North America Market Size by Type
6.2.1 North America POC HbA1C Testing Market Size by Type (2020-2031)
6.2.2 North America POC HbA1C Testing Market Share by Type (2020-2031)
6.3 North America Market Size by Application
6.3.1 North America POC HbA1C Testing Market Size by Application (2020-2031)
6.3.2 North America POC HbA1C Testing Market Share by Application (2020-2031)
6.4 North America Market Size by Country
6.4.1 North America POC HbA1C Testing Market Size by Country: 2020 VS 2024 VS 2031
6.4.2 North America POC HbA1C Testing Market Size by Country (2020-2031)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe POC HbA1C Testing Market Size (2020-2031)
7.2 Europe Market Size by Type
7.2.1 Europe POC HbA1C Testing Market Size by Type (2020-2031)
7.2.2 Europe POC HbA1C Testing Market Share by Type (2020-2031)
7.3 Europe Market Size by Application
7.3.1 Europe POC HbA1C Testing Market Size by Application (2020-2031)
7.3.2 Europe POC HbA1C Testing Market Share by Application (2020-2031)
7.4 Europe Market Size by Country
7.4.1 Europe POC HbA1C Testing Market Size by Country: 2020 VS 2024 VS 2031
7.4.2 Europe POC HbA1C Testing Market Size by Country (2020-2025)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries

8 China
8.1 China POC HbA1C Testing Market Size (2020-2031)
8.2 China Market Size by Type
8.2.1 China POC HbA1C Testing Market Size by Type (2020-2031)
8.2.2 China POC HbA1C Testing Market Share by Type (2020-2031)
8.3 China Market Size by Application
8.3.1 China POC HbA1C Testing Market Size by Application (2020-2031)
8.3.2 China POC HbA1C Testing Market Share by Application (2020-2031)

9 Asia (excluding China)
9.1 Asia POC HbA1C Testing Market Size (2020-2031)
9.2 Asia Market Size by Type
9.2.1 Asia POC HbA1C Testing Market Size by Type (2020-2031)
9.2.2 Asia POC HbA1C Testing Market Share by Type (2020-2031)
9.3 Asia Market Size by Application
9.3.1 Asia POC HbA1C Testing Market Size by Application (2020-2031)
9.3.2 Asia POC HbA1C Testing Market Share by Application (2020-2031)
9.4 Asia Market Size by Region
9.4.1 Asia POC HbA1C Testing Market Size by Region: 2020 VS 2024 VS 2031
9.4.2 Asia POC HbA1C Testing Market Size by Region (2020-2031)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
9.4.8 Australia

10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America POC HbA1C Testing Market Size (2020-2031)
10.2 Middle East, Africa, and Latin America Market Size by Type
10.2.1 Middle East, Africa, and Latin America POC HbA1C Testing Market Size by Type (2020-2031)
10.2.2 Middle East, Africa, and Latin America POC HbA1C Testing Market Share by Type (2020-2031)
10.3 Middle East, Africa, and Latin America Market Size by Application
10.3.1 Middle East, Africa, and Latin America POC HbA1C Testing Market Size by Application (2020-2031)
10.3.2 Middle East, Africa, and Latin America Market Share by Application (2020-2031)
10.4 Middle East, Africa, and Latin America Market Size by Country
10.4.1 Middle East, Africa, and Latin America POC HbA1C Testing Market Size by Country: 2020 VS 2024 VS 2031
10.4.2 Middle East, Africa, and Latin America POC HbA1C Testing Market Size by Country (2020-2031)
10.4.3 Brazil
10.4.4 Mexico
10.4.5 Turkey
10.4.6 Saudi Arabia
10.4.7 Israel
10.4.8 GCC Countries

11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott POC HbA1C Testing Introduction
11.1.4 Abbott Revenue in POC HbA1C Testing Business (2020-2025)
11.1.5 Abbott Recent Development
11.2 Siemens Healthineers
11.2.1 Siemens Healthineers Company Details
11.2.2 Siemens Healthineers Business Overview
11.2.3 Siemens Healthineers POC HbA1C Testing Introduction
11.2.4 Siemens Healthineers Revenue in POC HbA1C Testing Business (2020-2025)
11.2.5 Siemens Healthineers Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Roche Business Overview
11.3.3 Roche POC HbA1C Testing Introduction
11.3.4 Roche Revenue in POC HbA1C Testing Business (2020-2025)
11.3.5 Roche Recent Development
11.4 Bio-Rad
11.4.1 Bio-Rad Company Details
11.4.2 Bio-Rad Business Overview
11.4.3 Bio-Rad POC HbA1C Testing Introduction
11.4.4 Bio-Rad Revenue in POC HbA1C Testing Business (2020-2025)
11.4.5 Bio-Rad Recent Development
11.5 GREEN CROSS MEDIS
11.5.1 GREEN CROSS MEDIS Company Details
11.5.2 GREEN CROSS MEDIS Business Overview
11.5.3 GREEN CROSS MEDIS POC HbA1C Testing Introduction
11.5.4 GREEN CROSS MEDIS Revenue in POC HbA1C Testing Business (2020-2025)
11.5.5 GREEN CROSS MEDIS Recent Development
11.6 Trinity Biotech
11.6.1 Trinity Biotech Company Details
11.6.2 Trinity Biotech Business Overview
11.6.3 Trinity Biotech POC HbA1C Testing Introduction
11.6.4 Trinity Biotech Revenue in POC HbA1C Testing Business (2020-2025)
11.6.5 Trinity Biotech Recent Development
11.7 HUMAN Diagnostics
11.7.1 HUMAN Diagnostics Company Details
11.7.2 HUMAN Diagnostics Business Overview
11.7.3 HUMAN Diagnostics POC HbA1C Testing Introduction
11.7.4 HUMAN Diagnostics Revenue in POC HbA1C Testing Business (2020-2025)
11.7.5 HUMAN Diagnostics Recent Development
11.8 Sinocare (PTS Diagnostics)
11.8.1 Sinocare (PTS Diagnostics) Company Details
11.8.2 Sinocare (PTS Diagnostics) Business Overview
11.8.3 Sinocare (PTS Diagnostics) POC HbA1C Testing Introduction
11.8.4 Sinocare (PTS Diagnostics) Revenue in POC HbA1C Testing Business (2020-2025)
11.8.5 Sinocare (PTS Diagnostics) Recent Development
11.9 Erba Diagnostics
11.9.1 Erba Diagnostics Company Details
11.9.2 Erba Diagnostics Business Overview
11.9.3 Erba Diagnostics POC HbA1C Testing Introduction
11.9.4 Erba Diagnostics Revenue in POC HbA1C Testing Business (2020-2025)
11.9.5 Erba Diagnostics Recent Development
11.10 EKF Diagnostics
11.10.1 EKF Diagnostics Company Details
11.10.2 EKF Diagnostics Business Overview
11.10.3 EKF Diagnostics POC HbA1C Testing Introduction
11.10.4 EKF Diagnostics Revenue in POC HbA1C Testing Business (2020-2025)
11.10.5 EKF Diagnostics Recent Development
11.11 OSANG Healthcare
11.11.1 OSANG Healthcare Company Details
11.11.2 OSANG Healthcare Business Overview
11.11.3 OSANG Healthcare POC HbA1C Testing Introduction
11.11.4 OSANG Healthcare Revenue in POC HbA1C Testing Business (2020-2025)
11.11.5 OSANG Healthcare Recent Development
11.12 SD Biosensor
11.12.1 SD Biosensor Company Details
11.12.2 SD Biosensor Business Overview
11.12.3 SD Biosensor POC HbA1C Testing Introduction
11.12.4 SD Biosensor Revenue in POC HbA1C Testing Business (2020-2025)
11.12.5 SD Biosensor Recent Development
11.13 Aidian
11.13.1 Aidian Company Details
11.13.2 Aidian Business Overview
11.13.3 Aidian POC HbA1C Testing Introduction
11.13.4 Aidian Revenue in POC HbA1C Testing Business (2020-2025)
11.13.5 Aidian Recent Development
11.14 Boditech Med
11.14.1 Boditech Med Company Details
11.14.2 Boditech Med Business Overview
11.14.3 Boditech Med POC HbA1C Testing Introduction
11.14.4 Boditech Med Revenue in POC HbA1C Testing Business (2020-2025)
11.14.5 Boditech Med Recent Development
11.15 i-SENS
11.15.1 i-SENS Company Details
11.15.2 i-SENS Business Overview
11.15.3 i-SENS POC HbA1C Testing Introduction
11.15.4 i-SENS Revenue in POC HbA1C Testing Business (2020-2025)
11.15.5 i-SENS Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer